EIF3B and hepatocellular carcinoma: KO of eIF3a or eIF3b significantly suppressed the growth of HCC tumors (Fig. 3O–Q and Additional file 1: Fig. S3L–O) and elongated the disease-free survival (DFS) of the recipient mice in vivo (Fig. 3R).